A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design
- 31 December 1994
- Vol. 12 (2), 181-186
- https://doi.org/10.1016/0264-410x(94)90058-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 yearsVaccine, 1992
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987
- Malaria transmission and develoment of anti-sporozoite antibodies in a rural african communityMemórias do Instituto Oswaldo Cruz, 1986
- Specificity of protection of man immunized against sporozoite-induced falciparum malariaThe American Journal of the Medical Sciences, 1973
- Immunization of man against sporozite-induced falciparum malariaThe American Journal of the Medical Sciences, 1973